| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RTSN over the last quarter tilts toward buying: insiders added a net 30,800 shares worth roughly $370K. In the past 30 days, 2 insiders bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is Keller Eric L. (Chief Executive Officer), now holding an estimated $5.1M in RTSN. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
Classified under Biotechnology (Healthcare sector), RTSN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 423.4K | $5.08M | +20.8K | |
| Other | 406.6K | - | - | |
| Dir | 10.0K | $120.0K | +10.0K | |
| Dir | 5.6K | - | - | |
| Dir | 5.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Keller Eric L. | Chief Executive Officer | Buy | 20,800 | $12.00 | $249,600.00 | +5.2% | |
| Oct 13, 2026 | Berger Franklin M52 | Director | Buy | 10,000 | $12.00 | $120,000.00 | New |